News & Events

Read about the latest Nask news and events. Learn about innovative new products and technologies.

Sarinda Kwok (the co-founder and CEO of Profit Royal Pharmaceutical Limited) has been awarded “2026 Outstanding Women Professionals and Entrepreneurs Award”

We are deeply honored to announce that Sarinda Kwok (the co-founder and CEO of Profit Royal Pharmaceutical Limited) has been awarded “2026 Outstanding Women Professionals and Entrepreneurs Award”, in recognition of her outstanding achievements, leadership skills, innovative spirit and social responsibility in the professional and business fields. Corporate Development and the Role of Women in ESG Practices “It is our honour to be able to contribute to the betterment of the community.” – Sarinda Kwok With “Protect with Technology” as our motivation, we aim to turn bottlenecks into breakthroughs with our development in nanofiber technology. We strive for further progress while ensuring that our products not only comply with international safety and quality standards but also contribute to the environment and well-being of society as a whole. Besides, we also place significant efforts on setting up an environmental, social and governance (ESG) reporting system aligning with our value proposition to connect our ESG performance with operational plans and financial outcomes, including being a good steward of the environment and making progress on diversity, equity and inclusion. Through this approach, we are able to uphold our responsibilities to shareholders with respect to corporate sustainability while at the same time being responsible corporate citizen that delivers positive change and impact to society. Future Vision The Hong Kong Women Professionals and Entrepreneurs Association (HKWPEA) has served as a unifying force for women across the business and professional sectors—fostering professional exchange, actively contributing insights on public policy, and broadening the horizons of successive generations of women through the sharing of experience. Our company will channel this honor into fresh momentum, continuing to pursue excellence and contribute to society. Furthermore, we hope that our own experiences and achievements will inspire more women to break through barriers and realize their aspirations.

Advanced Performance Recognition – Hong Kong Caring Company Awards 2024/25

We are delighted and deeply honoured to announce that our company has been awarded Advanced Performance in the Hong Kong Caring Company Awards 2024/25. This prestigious designation serves as strong validation of our long-standing commitment and consistent performance in three key areas: Care for our people Contribution to the community Commitment to environmental sustainability Being placed in the Advanced Performance tier reflects the collective dedication of our employees, the trust and collaboration of our business partners, and the support of the wider community. We extend our sincere gratitude to every individual and organization that has walked alongside us on this meaningful journey. Moving forward, we remain firmly committed to embedding care, responsibility, and sustainability into our core business practices. We will continue to pursue impactful, measurable, and long-term contributions that create shared value for all stakeholders. We look forward to ongoing collaboration with like-minded partners to build a more inclusive, resilient, and sustainable Hong Kong. Thanks again to everyone who supports us!

Annual Lunch

NASK and Profit Royal Anniversary Lunch | A Day of Appreciation and Connection NASK’s anniversary dinner came to a wonderful close on February 7, marking a meaningful moment of celebration and reflection.On this special day, our team gathered to look back on the past year’s achievements and challenges. Beyond the enjoyable meal and exciting lucky draw, the event offered a great opportunity for colleagues to connect and share in a relaxed, cheerful atmosphere. This annual gathering was not only a celebration of our dedication and success but also a reminder of the strong bond that drives us forward as one team. A heartfelt thank-you to every colleague for your continuous effort and enthusiasm. Let’s carry this energy into another inspiring year ahead together!

IMDS BV Representative Dr.Alice Ho Visits NASK AMC Facility to Explore Collaboration Opportunities in Europe

NASK was honored to welcome Dr.Alice Ho, representative of IMDS BV, to visit our Production Center at the Advanced Manufacturing Centre (AMC) in Tseung Kwan O for a facility tour and strategic discussion. During the visit, Dr. Alice Ho was introduced to NASK’s proprietary nanofiber technology, our medical‑grade product portfolio and key quality management processes, followed by an in‑depth exchange with our R&D and business teams on market needs and application opportunities in Europe.​ With over 35 years of experience in international business development in the “Health & Beauty” and “Medical & Safety” sectors, IMDS BV has built an extensive network of distributors and retailers across Europe and beyond. This visit marks an important first step in exploring future collaboration opportunities, including the potential appointment of IMDS BV as NASK’s distribution partner in Europe, bringing Hong Kong‑developed nanofiber medical and safety solutions to a broader global audience.

FFP2 Surgical Respirator

We are happy to announce that we have successfully obtained the certification for our new product FFP2 surgical respirator RES-10, in compliance with Module B and D of the Personal Equipment Regulation (EU) 2016/425, standard EN149:2001+A1:2009; At the same time, we also get the certification of UKCA for this product. For the model M0011, we have successfully renewed the certification, in compliance with Module B and D of the Personal Equipment Regulation (EU) 2016/425, standard EN149:2001+A1:2009.

NASK Unveils New and Upgraded FFP3 Nanofiber Respirator

NASK announces the launch of a comprehensively upgraded FFP3 nanofiber respirator. As a global leader in nanofiber technology development, we are once again setting industry benchmarks with advanced patented nanofiber technology, delivering superior respiratory protection that meets the high standards of both medical professionals and the general public. The NASK FFP3 respirator’s standards are rigorously reviewed by the British Standards Institution (BSI), ensuring product excellence in various high-risk environments and meeting the highest international protective requirements, further solidifying our leading position in the market. Innovative Nanofiber Technology: Revolutionary Health Protection The NASK FFP3 respirator utilizes our unique patented nanofiber bactericidal technology, capable of killing 99% of bacteria and viruses, including COVID-19, influenza viruses, methicillin-resistant Staphylococcus aureus (MRSA), and superbugs within 5 minutes. Compared to the previous generation FFP2, our new FFP3 respirator boasts significant improvements in filtration efficiency and protective capabilities: Filtration Efficiency: The FFP3 respirator effectively filters 99% of the most penetrating particle size (MPPS), including potential pathogens, hydrocarbons, and heavy metals, providing more comprehensive protection than BFE/PFE/VFE standards. High Breathability: The FFP3 respirator is designed to be thinner and more breathable than the FFP2, with a nanofiber structure that ensures high-efficiency breathability, preventing hypoxemia (low level of oxygen in the blood) even during prolonged use, ensuring wearer comfort and safety. Comprehensive Functionality: Suitable not only for everyday protection for the general public, the FFP3 is especially designed for high-risk environments in healthcare settings, such as isolation wards or caring for patients with respiratory infections. 3D Comfortable Seal: The 3D sealing design minimizes leaks, with a fit test pass rate exceeding 99%. Comparative Analysis: FFP2 vs. FFP3 Compared to our FFP2 respirator, the FFP3 version offers a higher level of protection, suitable for more demanding work environments, including those with high concentrations of dust. Third-party laboratory tests confirm that

NASK Production and Manufacturing Center at AMC Achieves ISO 13485:2016 Certification

A significant stride in enhancing quality management of medical equipment has been taken as the production and manufacturing site at AMC Advanced Manufacturing Center receives ISO 13485:2016 certification. This accomplishment underscores NASK’s steadfast commitment to the highest quality standards, especially in the design and manufacturing of its pioneering nanofiber technology products. What is ISO 13485:2016? ISO 13485:2016 is an internationally recognized standard published in March 2016, setting out requirements for quality management systems where organizations must demonstrate their ability to consistently meet customer and applicable regulatory requirements in providing medical devices and related services. By obtaining the ISO 13485:2016 certification at our production and manufacturing center in AMC, we showcase our exceptional commitment to quality management systems for medical equipment manufacturers. Specifically designed for medical device manufacturers, this standard outlines requirements for a comprehensive quality management system, ensuring compliance with regulatory and customer requirements, safety standards, and the performance of medical devices. The ISO 13485:2016 certification validates NASK’s stringent quality control measures and its adherence to the highest standards in maintaining the production and development of medical equipment. This certification not only enhances the company’s reputation but also provides a competitive edge in the global market, ensuring recognition of NASK products for their quality and reliability. Why is ISO 13485:2016 Crucial for Scientific Medical Equipment Production Processes? Receiving the ISO 13485:2016 certification at the production facility in Tseung Kwan O AMC is not just about meeting international standards for NASK; it is about improving operational efficiency and product safety. This certification ensures that NASK can continue to deliver top-tier protection with products like its nanofiber respirators, guaranteeing safety, reliability, and quality. It supports the company’s innovative mission while adhering to strict regulatory requirements, ensuring that every product launched into the market is effective, safe, and suitable for global consumers. Upholding

Made in Hong Kong: The World’s First Antibacterial Mask – NASK Nanofiber Showcases The Scientific Research Prowess

Over the past decade in developing Nanofiber technology, Sarinda Kwok, the Co-founder and CEO of Profit Royal Pharmaceutical LTD, has witnessed the rise of Hong Kong’s scientific research. As a pioneer in the development of nanofiber technology, introducing this innovation posed a significant financial and resource investment with considerable risk for Profit Royal, which specializes in the development of health care products. However, Sarinda firmly believed in the immense potential of nanofiber technology as an innovative track for the industry. Her perseverance paid off when the research team succeeded in creating the world’s first antibacterial mask, which not only broke new ground but also found markets overseas, securing patents in the United States, Japan, China, and Hong Kong. During the COVID-19 pandemic, the company even prioritized local needs over international orders, dedicating their efforts to supporting the people of Hong Kong in the fight against the pandemic. Overcoming the pain point of traditional masks, NASK launched the world’s first respirator with antibacterial properties. Traditional masks have suffered from issues of inadequate protection or breathability. NASK Nanofiber respirator series, developed jointly by Profit Royal Pharmaceutical and local scientific research firms, boasts multiple functions including breathability, antibacterial action, and viral blocking properties. It can eliminate over 99% of bacteria and block viruses within five minutes. “The scenes from the SARS outbreak in 2003 are still vivid in my mind. Upon learning that nanofiber technology could be used to create masks that are highly protective and breathable, our company decided to invest in the development of this technology,” Sarinda continued. The advent of the NASK Nanofiber respirator not only meets market demand but does so with a production material cost that is only a third of that of traditional N95 masks, allowing for a more efficient use of production materials and contributing to

NASK NANOFIBER patented technology has won the gold award at the Hong Kong Institute of Engineers (HKIE)

NASK, with its revolutionary NASK NANOFIBER patented technology, has won the gold award at the Hong Kong Institution of Engineers. The Manufacturing, Industrial and Systems (MIS) Industrial Award from the Hong Kong Institute of Engineers (HKIE) is an award set to recognize the achievements and contributions of innovative technology and engineering professionals to the development of Hong Kong, covering three major categories: innovation, industry, and infrastructure engineering. The R&D team at NASK has become the sole gold award-winning scientific research team in the “Innovation Award” category of the recent HKIE MIS Industrial Award in Hong Kong. This honor demonstrates the NASK scientific research team’s determination to pursue excellence and innovation in the field of nanofiber technology. Setting New Standards in Innovative Technology The patented technology of NASK Nanofiber has remarkable features that make it stand out among other innovative technologies: Bactericidal: NASK has functionalized nanofibers to capture and kill over 99% of bacteria and viruses, and this technology has great potential for application in various fields. Ultra-thin and Highly Breathable: The NASK Nanofiber patented technology makes the material lighter while maintaining its original functions. Its high breathability not only ensures comfort for the wearer but also reduces air resistance through the fiber layer, thereby improving energy efficiency. Exceptional Filtration Performance: The NASK Nanofiber patented technology also achieves ultra-high filtration efficiency. Its nanofiber respirators, in addition to being internationally certified by PPE & NIOSH, can precisely capture and eliminate over 99% of bacteria and viruses, providing unparalleled protection. These characteristics highlight the wide applicability of the NASK Nanofiber patented technology, enabling breakthrough improvements and innovations in nanofiber technology in both the medical field and energy efficiency. This technology not only represents an innovative technological achievement but also opens up endless application possibilities, bringing revolutionary changes to various industries. NASK will continue